Sophiris Bio Inc. buy krebskrebs
Start price
03.05.20
/
50%
€0.20
Target price
04.11.21
€0.30
Performance (%)
-91.25%
End price
05.11.21
-
Summary
This prediction is currently being closed. The BUY prediction by krebskrebs for Sophiris Bio Inc. is performing very badly with a performance of -91.25%. krebskrebs has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Sophiris Bio Inc. | - | - | - | - |
| iShares Core DAX® | 1.301% | -1.386% | 12.259% | 59.752% |
| iShares Nasdaq 100 | 0.612% | -4.172% | 1.687% | 86.147% |
| iShares Nikkei 225® | 8.772% | 9.777% | 30.041% | 63.047% |
| iShares S&P 500 | 0.254% | -2.301% | 0.794% | 57.981% |
Comments by krebskrebs for this prediction
In the thread Sophiris Bio Inc. diskutieren
Buy mit Kursziel 0,3
In the thread Trading Sophiris Bio Inc.
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten

